Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system

References

• Abd El-Gawad AH, Zin El-Din E, Abd El-Alim H. (1988). Effect of surfactant incorporation techniques on sulphamethaxazole suppository formulations. Pharmazie 43:624–7
   PubMed Web of Science ®Google Scholar
• Abou El Ela AESF, Ibrahim EH, Allam AA. (2013). Bucco-adhesive tablets containing metoprolol tartarate: formulation, in vitro and in vivo characterization. J Drug Del Sci Tech 23:171–9
   Web of Science ®Google Scholar
• Ansel HC. (1985). Suppositories and other rectal, vaginal and urethral preparations. In: Williams and Wilkins, eds. Introduction to Pharmaceutical Dosage Forms, 4th ed. Philadelphia, USA: Lea & Febiger, 342–58
   Google Scholar
• Aqil M, Sultana Y, Ali A, et al. (2004). Transdermal drug delivery systems of a beta-blocker: design, in-vitro and in-vivo characterization. Drug Del 11:27–31
   PubMed Web of Science ®Google Scholar
• Asikoglu M, Ertan G, Cosar G. (1995). The release of isoconazole nitrate from different suppository bases: In-vitro dissolution, physicochemical and microbiological studies. J Pharm Pharmacol 47:713–16
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia. (2007). Vol. IV. Appendix XII G, A304. London, UK: The Stationary Office
   Google Scholar
• Bolourtchian N, Javid FS, Dadashzadeh S. (2005). The effect of various surfactants on release behavior of procainamide HCl from ethylcellulose based matrices. Iran J Pharm Res 1:13–9
   Google Scholar
• Calis S, Sumnu M, Hincal AA. (1994). Effect of suppository bases on the release properties of a potent antimicrobial agent (C31g). Pharmazie 49:336–9
   PubMed Web of Science ®Google Scholar
• Coben LJ, Lieberman HA. (1986). Suppositories. In: Lachman L, Lieberman HA, Kanig JL, eds. The Theory and Practices of Industrial Pharmacy. 3rd ed. Philadelphia, USA: Lea and Febiger, 564–88
   Google Scholar
• Coucke D, Vervaet C, Foreman P, et al. (2009). Effect on the nasal bioavailability of co-processing drug and bioadhesive carrier via spray drying. Int J Pharm 379:67–71
   PubMed Web of Science ®Google Scholar
• De Stoppelaar FM, Stolk LML, Beysens AJ, et al. (1999). The relative bioavailability of metoprolol following oral and rectal administration to volunteers and patients. Pharm World Sci 21:233–8
   PubMed Web of Science ®Google Scholar
• Dollery C. (1999). Metoprolol Tartrate. In: Boobis A, Rawlins M, Thomas S, Wilkins M, eds. Therapeutic Drugs, Vol. 2, 2nd ed. New York, USA: Churchill Livingston, M139–46
   Google Scholar
• El-Majri MA, Sharma RK. (2010). Formulation and evaluation of piroxicam suppositories. Int J Drug Del 2:108–12
   Google Scholar
• El-Nabarawi MA, Nesseem DI, Sleem AA. (2003). Delivery and analgesic activity of tramadol from semisolid (topical) and solid (rectal) dosage forms. Bull Fac Pharm Cairo Univ 41:25–31
   Google Scholar
• El-Shanawany S, Aly SA. (1994). Formulation of propranolol hydrochloride suppositories and pharmacological evaluation in rabbits. Eur J Pharm Biopharm 40:327–32
   Web of Science ®Google Scholar
• Eman G, Mokhtar M, El Ghamry H, Ghazy F. (2012). Sustained release rectal suppositories as drug delivery systems for atenolol. J Am Sci 8:323–32
   Google Scholar
• Geoffrey B, James H. (2005). The origin of scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J Exp Bio 208:1575–92
   PubMed Web of Science ®Google Scholar
• Ghorab D, Refai H, Tag R. (2011). Preparation and evaluation of fenoterol hydrobromide suppositories. Drug Dis Therap 5:311–8
   PubMedGoogle Scholar
• Grant DJW, Liversage GG, Bell J. (1983). Influence of physicochemical interactions on the properties of suppositories. The in-vitro release of ketoprofen and metronidazole from various fatty suppository bases and the relations with in-vivo plasma levels. Int J Pharm 14:251–61
   Web of Science ®Google Scholar
• Hanaee J, Javadzadeh Y, Taftachi S, et al. (2004). The role of various surfactants on the release of salbutamol from suppositories. Farmaco 59:903–6
   PubMedGoogle Scholar
• Hassan MA, Mahfouz NM. (2001). Formulation and evaluation of ciprofloxacin hydrochloride suppositories. Bull Pharm SciAssiut University 24:47–54
   Google Scholar
• Hosny EA, Abdel-Hady SS, El-Tahir KEH. (1996). Formulation, in-vitro release and ex-vivo spasmolytic effects of mebeverine hydrochloride suppositories containing polycarpophil or polysorbate 80. Int J Pharm 142:163–8
   Web of Science ®Google Scholar
• Hussain A, Hirai S, Bawarshi R. (1980). Nasal absorption of propranolol from different dosage forms by rats and dogs. J Pharm Sci 69:1411–13
   PubMed Web of Science ®Google Scholar
• Issa M, Mohamed A, Seham B. (2009). Synthesis and pharmacological evaluation of 2-substituted benzo[b]thiophenes as anti-inflammatory and analgesic agents. EurJ Med Chem 44:1718–25
   PubMed Web of Science ®Google Scholar
• Katzung BG. (1995). Basic and Clinical Pharmacology, 6th ed. Appleton & Lange, Middle East Edition, 205–29
   Google Scholar
• Moffat AC. (1986). Metoprolol tartrate. In: Jackson JV, Moss MS, Widdop B, eds. Clarke's isolation and identification of drugs, 2nd ed. London, UK: The Pharmaceutical Press Inc., 779–80
   Google Scholar
• Nair L, Bhargava HN. (1999). Comparison of in-vitro dissolution and permeation of fluconazole from different suppository bases. Drug Dev Ind Pharm 25:691–94
   PubMed Web of Science ®Google Scholar
• Ramana MV, Nagda C, Himaja M. (2007). Design and evaluation of mucoadhesivebuccal drug delivery systems containing metoprolol tartrate. Ind J Pharm Sci 69: 515–18
   Google Scholar
• Realdon N, Ragazzi E. (2001). Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients. Pharmazie 56:163–7
   PubMed Web of Science ®Google Scholar
• Realdon N, Dal zotto M, Morpurgo M, Franceschinis E. (2008). Effects of surfactant characteristics on drug availability from suppositories. Pharmazie 63:459–63
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. (2009). Handbook of Pharmaceutical Excipients, 6th ed. London, UK: Pharmaceutical Press
   Google Scholar
• Ryu JM, Chung SJ, Lee MH, et al. (1999). Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum. J Control Rel 59:163–72
   PubMed Web of Science ®Google Scholar
• Saleem MA, Taher M, Sanaullah S, et al. (2008). Formulation and evaluation of tramadol hydrochloride rectal suppositories. Ind J Pharm Sci 70:640–4
   PubMedGoogle Scholar
• Samy EM, Hassan MA, Tous SS, Rhodes CT. (2000). Improvement of availability of allopurinol from pharmaceutical dosage forms I-Suppositories. Eur J Pharm Biopharm 49:119–27
   PubMed Web of Science ®Google Scholar
• Tukker J. (2009). Rectal and vaginal drug delivery. In: Aulton ME, ed. Pharmaceutics, the science of dosage form design. Edinburgh, UK: Churchill Livingstone, 534–43
   Google Scholar
• Weibel E, Bacigalupe L, Schmitt B, Hoppeler H. (2004). Allometric scaling of maximal metabolic rate in mammals: muscle aerobic capacity as determined factor. J Physiol Neurobiol 140:115–32
   PubMed Web of Science ®Google Scholar
• Zuheir A, Samein LH, Aiash N. (2013). Preparation and in vitro evaluation of metoclopramide HCL hollow-type suppository. Int J Pharm Pharm Sci 5:660–6
   Google Scholar